Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Caremark Rx, Inc./AdvancePCS, In the Matter of
Tenet Healthcare Corporation and Frye Regional Medical Center, Inc.
A consent order prohibits Frye Regional Medical Center, Inc., an acute care hospital in Hickory, North Carolina, and its parent company Tenet Healthcare Corporation from entering into any agreement to negotiate fees on behalf of any physician practicing in four North Carolina counties and from refusing to deal with insurance companies and other payers. Also refer to related administrative complaint issued to Piedmont Health Alliance. This settlement is the first case in which the Commission has named a hospital as a participant in an alleged physician price-fixing conspiracy.
Perfumes Unlimited, Inc., et al., Defendant Lon Finkelstein., U.S.
Global Web Solutions Inc. et al.
Wright Medical Technology, Inc., et al.
Memorial Hermann Health Network Providers
Sunoco Inc. and Coastal Eagle Point Oil Company., In the Matter of
Piedmont Health Alliance, Inc.; et al.
Schering-Plough Corporation, Upsher-Smith Laboratories, and American Home Products Corporation, In the Matter of
In the complaint dated March 30, 2001 the Commission alleged that Schering - Plough, the manufacturer of K-Dur 20 - a prescribed potassium chloride, used to treat patients with low blood potassium levels - entered into anticompetitive agreements with Upsher-Smith Laboratories and American Home Products Corporation to delay their generic versions of the K-Dur 20 drug from entering the market. According to the charges, Schering-Plough paid Upsher- Smith $60 million and paid American Home Products $15 million to keep the low-cost generic version of the drug off the market. The charges against American Home Products were settled by a consent agreement. An initial decision filed July 2, 2002 dismissed all charges against Schering - Plough and Upsher-Smith Laboratories. On December 8, 2003 the Commission reversed the administrative law judge’s initial decision and found that Schering-Plough Corporation entered into agreements with Upsher-Smith Laboratories, Inc. and American Home Products to delay the entry of generic versions of Schering’s branded K-Dur 20. According to the opinion, the parties settled patent litigation with terms that included unconditional payments by Schering in return for agreements to defer introduction of the generic products. The Commission entered an order that would bar similar conduct in the future. The United States Court of Appeals for the Eleventh Circuit set aside and vacated the Commission decision finding that the agreements were immune from antitrust review if their anticompetitive effects were within the scope of the exclusionary potential of the patent. The Commission filed a petition for writ of certiorari with the U.S. Supreme Court in August 2005, which the Court denied.
Membership Services, Inc. and James M. Schwindt., FTC and Illinois
Interact Communications, Inc., et al.
New Hampshire Motor Transport Association
The New Hampshire Motor Transport Association settled charges that it filed tariffs on behalf of its 400 members containing rules that called for automatic increases in intrastate rates during the summer months, conduct that was not protected by the state action doctrine because it was not actively supervised by the state. In addition, the organization agreed to void its collectively filed tariffs current in effect in New Hampshire, ensuring that future tarriff provisions would be filed individually.